Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 61 matching records.
61 results — page 1 of 3
- Level AMeta-analysisEurope PMC
Efficacy and safety of stem cell therapy for myocardial infarction and heart failure: an updated systematic review and meta-analysis of randomized controlled trials
Meta-analysis with a reported sample of 3345 on Cardiovascular Disease, Stroke Research, published in Syst Rev (2026) — summary generated from the PubMed abstract.
- 2026
- n = 3345
Syst Rev - Level BRandomized Controlled TrialPubMed
Adipose tissue-derived mesenchymal stromal cell therapy in nonischemic heart failure with reduced ejection fraction - ARIISE study design.
Randomized Controlled Trial on Cardiovascular Disease, Stroke Research, Immune Modulation, published in Future Cardiol (2026) — summary generated from the PubMed abstract.
- 2026
Future Cardiol - Level DNarrative ReviewEurope PMC
Hydrogels loaded with different substances for treating heart failure: a promising therapy
Narrative Review on Cardiovascular Disease, published in Front Cardiovasc Med (2026) — summary generated from the PubMed abstract.
- 2026
Front Cardiovasc Med - Level AMeta-analysisEurope PMC
Safety and Efficacy of Transendocardial Stem Cells Therapy in Chronic Ischemic Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Meta-analysis on Cardiovascular Disease, Stroke Research, published in Curr Cardiol Rev (2025) — summary generated from the PubMed abstract.
- 2025
Curr Cardiol Rev - Level ASystematic ReviewEurope PMC
Assessing the Potential Benefits of Stem Cell Therapy in Cardiac Regeneration for Patients With Ischemic Heart Disease
Systematic Review on Cardiovascular Disease, published in Cureus (2025) — summary generated from the PubMed abstract.
- 2025
Cureus7 citations - Level DNarrative ReviewEurope PMC
Current state of heart failure treatment: are mesenchymal stem cells and their exosomes a future therapy?
Narrative Review on Cardiovascular Disease, published in Front Cardiovasc Med (2025) — summary generated from the PubMed abstract.
- 2025
Front Cardiovasc Med3 citations - Level AMeta-analysisEurope PMC
Cardiac Repair and Clinical Outcomes of Stem Cell Therapy in Heart Failure: A Systematic Review and Meta-Analysis
Meta-analysis on Cardiovascular Disease, published in Diseases (2025) — summary generated from the PubMed abstract.
- 2025
Diseases - Level DNarrative ReviewEurope PMC
Exploring hiPSC-CM replacement therapy in ischemic hearts
Narrative Review on Cardiovascular Disease, published in Basic Res Cardiol (2025) — summary generated from the PubMed abstract.
- 2025
Basic Res Cardiol - Level DNarrative ReviewEurope PMC
Hydrogel based scaffolds in cardiovascular disease: applications in myocardial regeneration, biological pacing, and heart failure therapy
Narrative Review on Cardiovascular Disease, published in Front Cell Dev Biol (2025) — summary generated from the PubMed abstract.
- 2025
Front Cell Dev Biol - Level DNarrative ReviewPubMed
Stem Cell Therapy against Ischemic Heart Disease.
Narrative Review on Cardiovascular Disease, published in Int J Mol Sci (2024) — summary generated from the PubMed abstract.
- 2024
Int J Mol Sci14 citations - Level ASystematic ReviewPubMed
Stem Cell Therapy for Myocardial Infarction and Heart Failure: A Comprehensive Systematic Review and Critical Analysis.
Systematic Review on Cardiovascular Disease, published in Cureus (2024) — summary generated from the PubMed abstract.
- 2024
Cureus4 citations - Level ASystematic ReviewPubMed
Safety and Efficacy of Adipose-Derived Mesenchymal Stem Cell Therapy for Ischemic Heart Disease: A Systematic Review.
Systematic Review on Cardiovascular Disease, published in Arq Bras Cardiol (2024) — summary generated from the PubMed abstract.
- 2024
Arq Bras Cardiol3 citations - Level DNarrative ReviewEurope PMC
In Search of the Holy Grail: Stem Cell Therapy as a Novel Treatment of Heart Failure with Preserved Ejection Fraction
Narrative Review on Cardiovascular Disease, Stroke Research, Immune Modulation, published in Int J Mol Sci (2023) — summary generated from the PubMed abstract.
- 2023
Int J Mol Sci4 citations - Level BClinical TrialPubMed
Cell therapy in patients with heart failure: a comprehensive review and emerging concepts.
Clinical Trial on Cardiovascular Disease, published in Cardiovasc Res (2022) — summary generated from the PubMed abstract.
- 2022
Cardiovasc Res82 citations - Level BClinical TrialEurope PMC
Mesenchymal Stem Cell (MSCs) Therapy for Ischemic Heart Disease: A Promising Frontier
Clinical Trial on Cardiovascular Disease, Immune Modulation, published in Glob Heart (2022) — summary generated from the PubMed abstract.
- 2022
Glob Heart37 citations - Level AMeta-analysisEurope PMC
Meta-Analysis of Percutaneous Endomyocardial Cell Therapy in Patients with Ischemic Heart Failure by Combination of Individual Patient Data (IPD) of ACCRUE and Publication-Based Aggregate Data
Meta-analysis with a reported sample of 8 on Cardiovascular Disease, published in J Clin Med (2022) — summary generated from the PubMed abstract.
- 2022
- n = 8
J Clin Med5 citations - Level DNarrative ReviewEurope PMC
The Progress of Stem Cell Therapy in Myocardial-Infarcted Heart Regeneration: Cell Sheet Technology
Narrative Review on Cardiovascular Disease, published in Tissue Eng Regen Med (2022) — summary generated from the PubMed abstract.
- 2022
Tissue Eng Regen Med7 citations - Level DLaboratory StudyPubMed
Cross talk of vasopressin conditioned cell therapy in ischemic heart disease: Role of oxidative stress markers.
Laboratory Study on Cardiovascular Disease, published in Iran J Basic Med Sci (2022) — summary generated from the PubMed abstract.
- 2022
Iran J Basic Med Sci - Level BClinical TrialEurope PMC
Contemporary Challenges of Regenerative Therapy in Patients with Ischemic and Non-Ischemic Heart Failure
Clinical Trial on Cardiovascular Disease, published in J Cardiovasc Dev Dis (2022) — summary generated from the PubMed abstract.
- 2022
J Cardiovasc Dev Dis7 citations - Level DNarrative ReviewEurope PMC
Cellular signaling cross-talk between different cardiac cell populations: an insight into the role of exosomes in the heart diseases and therapy
Narrative Review on Cardiovascular Disease, published in Am J Physiol Heart Circ Physiol (2021) — summary generated from the PubMed abstract.
- 2021
Am J Physiol Heart Circ Physiol27 citations - Level DAnimal StudyPubMed
Adiponectin Stimulates Exosome Release to Enhance Mesenchymal Stem-Cell-Driven Therapy of Heart Failure in Mice.
Animal Study on Cardiovascular Disease, published in Mol Ther (2020) — summary generated from the PubMed abstract.
- 2020
Mol Ther - Level DNarrative ReviewEurope PMC
Progress and Challenges of Amniotic Fluid Derived Stem Cells in Therapy of Ischemic Heart Disease
Narrative Review on Cardiovascular Disease, published in Int J Mol Sci (2020) — summary generated from the PubMed abstract.
- 2020
Int J Mol Sci9 citations - Level BRandomized Controlled TrialPubMed
Rationale and design of the European multicentre study on Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE).
Randomized Controlled Trial with a reported sample of 58 on Cardiovascular Disease, Stroke Research, published in Eur J Heart Fail (2019) — summary generated from the PubMed abstract.
- 2019
- n = 58
Eur J Heart Fail40 citations - Level DNarrative ReviewEurope PMC
Mesenchymal Stem Cell Therapy for Doxorubicin-Induced Cardiomyopathy: Potential Mechanisms, Governing Factors, and Implications of the Heart Stem Cell Debate
Narrative Review on Cardiovascular Disease, Chronic Inflammation, published in Front Pharmacol (2019) — summary generated from the PubMed abstract.
- 2019
Front Pharmacol40 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406